At the ESMO Congress 2025 in Berlin, Dr. Martina Carullo (Pisa, Italy) presented groundbreaking findings from the translational program of AtezoTRIBE and AVETRIC, two clinical trials exploring immunotherapy in proficient mismatch…
AtezoTRIBE and AVETRIC Results at ESMO 2025: AI-Powered Histopathology Predicts Immunotherapy Benefit in pMMR mCRC
